Find Terazosin HCl manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

API REF. PRICE (USD/KG)

MARKET PLACE

0

FDF

0INTERMEDIATES

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

JP

PATENTS & EXCLUSIVITIES

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

GLOBAL SALES INFORMATION

Annual Reports

NA

134 RELATED EXCIPIENT COMPANIES

222EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 63074-08-8, Terazosin hcl, Hytrin, Fosfomic, Zayasel, Blavin
Molecular Formula
C19H26ClN5O4
Molecular Weight
423.9  g/mol
InChI Key
IWSWDOUXSCRCKW-UHFFFAOYSA-N
FDA UNII
8QOP8Z9955

Terazosin HCl
1 2D Structure

Terazosin HCl

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(oxolan-2-yl)methanone;hydrochloride
2.1.2 InChI
InChI=1S/C19H25N5O4.ClH/c1-26-15-10-12-13(11-16(15)27-2)21-19(22-17(12)20)24-7-5-23(6-8-24)18(25)14-4-3-9-28-14;/h10-11,14H,3-9H2,1-2H3,(H2,20,21,22);1H
2.1.3 InChI Key
IWSWDOUXSCRCKW-UHFFFAOYSA-N
2.1.4 Canonical SMILES
COC1=C(C=C2C(=C1)C(=NC(=N2)N3CCN(CC3)C(=O)C4CCCO4)N)OC.Cl
2.2 Other Identifiers
2.2.1 UNII
8QOP8Z9955
2.3 Synonyms
2.3.1 MeSH Synonyms

1. A 45975

2. Adecur

3. Apo-terazosin

4. Deflox

5. Dysalfa

6. Flotrin

7. Heitrin

8. Hytrin

9. Hytrin Bph

10. Hytrine

11. Magnurol

12. Novo-terazosin

13. Nu-terazosin

14. Pms-terazosin

15. Ratio-terazosin

16. Sutif

17. Tazusin

18. Terazoflo

19. Terazosin

20. Terazosin Azu

21. Terazosin Hexal

22. Terazosin Hydrochloride Anhydrous

23. Terazosin, Monohydrochloride, Dihydrate

24. Terazosina Alter

25. Terazosina Kern

26. Terazosina Qualix

27. Zayasel

2.3.2 Depositor-Supplied Synonyms

1. 63074-08-8

2. Terazosin Hcl

3. Hytrin

4. Fosfomic

5. Zayasel

6. Blavin

7. Terazosin Hydrochloride Anhydrous

8. Vasocard

9. (4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl)(tetrahydrofuran-2-yl)methanone Hydrochloride

10. Flumarc

11. Mls000040261

12. Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)-, Monohydrochloride

13. Terazosin (hydrochloride)

14. 8qop8z9955

15. Terazocin Hydrochloride (anhydrous)

16. Smr000044015

17. Dsstox_cid_25493

18. Dsstox_rid_80913

19. Dsstox_gsid_45493

20. 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]piperazine Hydrochloride

21. 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)4-[(tetrahydro-2-furanyl)carbonyl]piperazine Hydrochloride

22. Abbott-45975 Anhydrous

23. Cas-63074-08-8

24. Sr-01000000197

25. Unii-8qop8z9955

26. Prestwick_146

27. Opera_id_398

28. Ncgc00016903-01

29. Schembl41545

30. Terazosin Hydrochloride,pharma

31. Mls001077301

32. Mls001305722

33. Chembl1256665

34. Dtxsid7045493

35. Hy-b0371f

36. Hms1570g04

37. Pharmakon1600-01505576

38. Bcp12795

39. Terazosin Hydrochloride [mi]

40. Tox21_110674

41. Mfcd00467965

42. Nsc759168

43. S4679

44. Akos007930686

45. Tox21_110674_1

46. Ac-2074

47. Ccg-220751

48. Lp01138

49. Ncgc00016026-10

50. Ncgc00094404-01

51. Ncgc00094404-02

52. Terazosin Hydrochloride, Anhydrous

53. Ds-11401

54. Db-018541

55. Cs-0013075

56. Eu-0101138

57. Ft-0605647

58. T2751

59. D11585

60. D70611

61. T 4680

62. Terazosin Hydrochloride, >=98% (tlc), Powder

63. 074t088

64. Terazosin Hydrochloride Anhydrous [who-dd]

65. Sr-01000000197-2

66. Sr-01000000197-4

67. Q27270906

68. Sr-01000000197-12

69. 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)-piperazine Hydrochloride

70. 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine Hydrochloride

71. 2[4-(tetrahydro-2-furoy1)piperazinyl]-4-amino-6,7-dimethoxyquinazoline Hydrochloride

72. 4-amino-6,7-dimethoxy-2-[4-(tetrahydro-2-furoyl)-1-piperazinyl]quinazoline Hydrochloride

73. (4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl)(tetrahydrofuran-2-yl)methanonehydrochloride

74. [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(oxolan-2-yl)methanone;hydrochloride

75. [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(oxolan-2-yl)methanone;hydron;chloride

76. 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]-piperazine Hydrochloride

77. Methanone, (4-(4-amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl)(tetrahydro-2-furanyl)-, Hydrochloride (1:1)

78. Piperazine,1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]-, Monohydrochloride

2.4 Create Date
2005-08-08
3 Chemical and Physical Properties
Molecular Weight 423.9 g/mol
Molecular Formula C19H26ClN5O4
Hydrogen Bond Donor Count2
Hydrogen Bond Acceptor Count8
Rotatable Bond Count4
Exact Mass423.1673320 g/mol
Monoisotopic Mass423.1673320 g/mol
Topological Polar Surface Area103 Ų
Heavy Atom Count29
Formal Charge0
Complexity544
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count1
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count2
4 Drug and Medication Information
4.1 Drug Information
1 of 2  
Drug NameTerazosin hydrochloride
Drug LabelTerazosin hydrochloride, an alpha-1-selective adrenoceptor blocking agent, is a quinazoline derivative represented by the following chemical name and structural formula: (RS)-Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furan...
Active IngredientTerazosin hydrochloride
Dosage FormCapsule
RouteOral
Strengtheq 5mg base; eq 2mg base; eq 1mg base; eq 10mg base
Market StatusPrescription
CompanyJubilant Cadista; Apotex; Sandoz; Ivax Sub Teva Pharms; Mylan

2 of 2  
Drug NameTerazosin hydrochloride
Drug LabelTerazosin hydrochloride, an alpha-1-selective adrenoceptor blocking agent, is a quinazoline derivative represented by the following chemical name and structural formula: (RS)-Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furan...
Active IngredientTerazosin hydrochloride
Dosage FormCapsule
RouteOral
Strengtheq 5mg base; eq 2mg base; eq 1mg base; eq 10mg base
Market StatusPrescription
CompanyJubilant Cadista; Apotex; Sandoz; Ivax Sub Teva Pharms; Mylan

5 Pharmacology and Biochemistry
5.1 MeSH Pharmacological Classification

Urological Agents

Drugs used in the treatment of urological conditions and diseases such as URINARY INCONTINENCE and URINARY TRACT INFECTIONS. (See all compounds classified as Urological Agents.)


Adrenergic alpha-1 Receptor Antagonists

Drugs that bind to and block the activation of ADRENERGIC ALPHA-1 RECEPTORS. (See all compounds classified as Adrenergic alpha-1 Receptor Antagonists.)


5.2 FDA Pharmacological Classification
5.2.1 Pharmacological Classes
alpha-Adrenergic Blocker [EPC]; Adrenergic alpha-Antagonists [MoA]

API SUPPLIERS

read-more
read-more
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

read-more
read-more
[{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q3","strtotime":1629138600,"product":"TERAZOSIN HYDROCHLORIDE (TERAZOSIN HCL D IHYDRATE)","address":"B-5 INDUSTRIAL ESTATE,P.B.1911SANATHNAGAR","city":"HYDERABAD ,ANDHRA PRADESH","supplier":"SYNTHOKEM LABS","supplierCountry":"INDIA","foreign_port":"BUENOS AIRES","customer":"TO THE ORDER OF.,","customerCountry":"ARGENTINA","quantity":"75.00","actualQuantity":"75","unit":"KGS","unitRateFc":"696","totalValueFC":"50710.9","currency":"USD","unitRateINR":50147.959999999999,"date":"17-Aug-2021","totalValueINR":"3761097","totalValueInUsd":"50710.9","indian_port":"HYDERABAD AIR","hs_no":"29349990","bill_no":"3908335","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ARGENTINA","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"B-5 INDUSTRIAL ESTATE,P.B.1911SANATHNAGAR, HYDERABAD ,ANDHRA PRADESH","customerAddress":""},{"dataSource":"API Import","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1637865000,"product":"TERAZOSIN HCL","address":"PLOT NO.47, 3RD, FLOOR, INDUSTRIAL ,DEVELOPMENT AREA, BALANAGAR","city":"HYDERABAD,TELANGANA","supplier":"TEVA API","supplierCountry":"ITALY","foreign_port":"NA","customer":"ASPHAR RESEARCH LABS PVT LTD","customerCountry":"INDIA","quantity":"1.50","actualQuantity":"1.5","unit":"KGS","unitRateFc":"2140","totalValueFC":"3237.1","currency":"USD","unitRateINR":"160714","date":"26-Nov-2021","totalValueINR":"241071","totalValueInUsd":"3237.1","indian_port":"HYDERABAD AIR","hs_no":"29333919","bill_no":"6423343","productDescription":"API","marketType":"REGULATED MARKET","country":"ITALY","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"PLOT NO.47, 3RD, FLOOR, INDUSTRIAL ,DEVELOPMENT AREA, BALANAGAR"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1647628200,"product":"TERAZOSIN HCL USP -500GRAM (FOR R&D PURPOSE)","address":"AJANTA HOUSE. 98 GOVT. IND. AREA CHARKOP KANDIVALI WEST Contact No:","city":"MUMBAI","supplier":"BIOINDUSTRIA L.I.M. SPA","supplierCountry":"ITALY","foreign_port":"NA","customer":"AJANTA PHARMA LIMITED","customerCountry":"INDIA","quantity":"0.50","actualQuantity":"0.5","unit":"KGS","unitRateFc":"5000","totalValueFC":"2802.8","currency":"EUR","unitRateINR":"427250","date":"19-Mar-2022","totalValueINR":"213625","totalValueInUsd":"2802.8","indian_port":"BOMBAY AIR","hs_no":"29349990","bill_no":"7925971","productDescription":"API","marketType":"REGULATED MARKET","country":"ITALY","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"AJANTA HOUSE. 98 GOVT. IND. AREA CHARKOP KANDIVALI WEST Contact No:"},{"dataSource":"API Import","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1658687400,"product":"TERAZOSIN HCL USP((BATCH NO.TZ2022\/00077 & TZ2022\/00078)","address":"98, GOVT.INDUSTRIAL AREA,","city":"MUMBAI.","supplier":"BIOINDUSTRIA L.I.M. SPA","supplierCountry":"ITALY","foreign_port":"N\/A","customer":"AJANTA PHARMA LIMITED","customerCountry":"INDIA","quantity":"14.00","actualQuantity":"14","unit":"KGS","unitRateFc":"1851.1","totalValueFC":"26383.2","currency":"USD","unitRateINR":"149850","date":"25-Jul-2022","totalValueINR":"2097900","totalValueInUsd":"26383.2","indian_port":"Dahez-SEZ","hs_no":"29349990","bill_no":"1003489","productDescription":"API","marketType":"REGULATED MARKET","country":"ITALY","selfForZScoreResived":"Pharma Grade","supplierPort":"N\/A","supplierAddress":"15067 NOVI LIGURE (AL) VA DE AMBROS IIS 2 Italy","customerAddress":"98, GOVT.INDUSTRIAL AREA,"},{"dataSource":"API Import","activeIngredients":"","year":"2023","qtr":"Q1","strtotime":1679682600,"product":"TERAZOSIN HCL USP (FOR R&D PURPOSE)","address":"AJANTA HOUSE. 98 GOVT. IND. AREA CHARKOP KANDIVALI WEST Contact No:","city":"MUMBAI","supplier":"BIOINDUSTRIA L.I.M. SPA","supplierCountry":"ITALY","foreign_port":"NA","customer":"AJANTA PHARMA LIMITED","customerCountry":"INDIA","quantity":"2.00","actualQuantity":"2","unit":"KGS","unitRateFc":"2000","totalValueFC":"4345.3","currency":"EUR","unitRateINR":"178700","date":"25-Mar-2023","totalValueINR":"357400","totalValueInUsd":"4345.3","indian_port":"BOMBAY AIR","hs_no":"29349990","bill_no":"5224296","productDescription":"API","marketType":"REGULATED MARKET","country":"ITALY","selfForZScoreResived":"Pharma Grade","supplierPort":"NA","supplierAddress":"","customerAddress":"AJANTA HOUSE. 98 GOVT. IND. AREA CHARKOP KANDIVALI WEST Contact No:"}]
17-Aug-2021
25-Mar-2023
KGS
overview
Loading...

Average Price (USD/KGS)

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country Total Quantity
(KGS)
Average Price
(USD/KGS)
Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

read-more
read-more

Direct Compression

read-more
read-more

Thickeners and Stabilizers

read-more
read-more

Lubricants & Glidants

read-more
read-more

Coating Systems & Additives

read-more
read-more

Co-Processed Excipients

read-more
read-more

Granulation

read-more
read-more

Disintegrants & Superdisintegrants

read-more
read-more

Film Formers & Plasticizers

read-more
read-more

Empty Capsules

read-more
read-more

Taste Masking

read-more
read-more

Controlled & Modified Release

read-more
read-more

Chewable & Orodispersible Aids

read-more
read-more

Topical

read-more
read-more

Emulsifying Agents

read-more
read-more

Coloring Agents

read-more
read-more

Parenteral

read-more
read-more

Solubilizers

read-more
read-more

API Stability Enhancers

read-more
read-more

Surfactant & Foaming Agents

read-more
read-more

Rheology Modifiers

read-more
read-more

Digital Content read-more

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Terazosin HCl Manufacturers

A Terazosin HCl manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Terazosin HCl, including repackagers and relabelers. The FDA regulates Terazosin HCl manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Terazosin HCl API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Terazosin HCl manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Terazosin HCl Suppliers

A Terazosin HCl supplier is an individual or a company that provides Terazosin HCl active pharmaceutical ingredient (API) or Terazosin HCl finished formulations upon request. The Terazosin HCl suppliers may include Terazosin HCl API manufacturers, exporters, distributors and traders.

click here to find a list of Terazosin HCl suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Terazosin HCl USDMF

A Terazosin HCl DMF (Drug Master File) is a document detailing the whole manufacturing process of Terazosin HCl active pharmaceutical ingredient (API) in detail. Different forms of Terazosin HCl DMFs exist exist since differing nations have different regulations, such as Terazosin HCl USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Terazosin HCl DMF submitted to regulatory agencies in the US is known as a USDMF. Terazosin HCl USDMF includes data on Terazosin HCl's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Terazosin HCl USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Terazosin HCl suppliers with USDMF on PharmaCompass.

Terazosin HCl KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Terazosin HCl Drug Master File in Korea (Terazosin HCl KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Terazosin HCl. The MFDS reviews the Terazosin HCl KDMF as part of the drug registration process and uses the information provided in the Terazosin HCl KDMF to evaluate the safety and efficacy of the drug.

After submitting a Terazosin HCl KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Terazosin HCl API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Terazosin HCl suppliers with KDMF on PharmaCompass.

Terazosin HCl CEP

A Terazosin HCl CEP of the European Pharmacopoeia monograph is often referred to as a Terazosin HCl Certificate of Suitability (COS). The purpose of a Terazosin HCl CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Terazosin HCl EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Terazosin HCl to their clients by showing that a Terazosin HCl CEP has been issued for it. The manufacturer submits a Terazosin HCl CEP (COS) as part of the market authorization procedure, and it takes on the role of a Terazosin HCl CEP holder for the record. Additionally, the data presented in the Terazosin HCl CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Terazosin HCl DMF.

A Terazosin HCl CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Terazosin HCl CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of Terazosin HCl suppliers with CEP (COS) on PharmaCompass.

Terazosin HCl WC

A Terazosin HCl written confirmation (Terazosin HCl WC) is an official document issued by a regulatory agency to a Terazosin HCl manufacturer, verifying that the manufacturing facility of a Terazosin HCl active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Terazosin HCl APIs or Terazosin HCl finished pharmaceutical products to another nation, regulatory agencies frequently require a Terazosin HCl WC (written confirmation) as part of the regulatory process.

click here to find a list of Terazosin HCl suppliers with Written Confirmation (WC) on PharmaCompass.

Terazosin HCl NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Terazosin HCl as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Terazosin HCl API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Terazosin HCl as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Terazosin HCl and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Terazosin HCl NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Terazosin HCl suppliers with NDC on PharmaCompass.

Terazosin HCl GMP

Terazosin HCl Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Terazosin HCl GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Terazosin HCl GMP manufacturer or Terazosin HCl GMP API supplier for your needs.

Terazosin HCl CoA

A Terazosin HCl CoA (Certificate of Analysis) is a formal document that attests to Terazosin HCl's compliance with Terazosin HCl specifications and serves as a tool for batch-level quality control.

Terazosin HCl CoA mostly includes findings from lab analyses of a specific batch. For each Terazosin HCl CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Terazosin HCl may be tested according to a variety of international standards, such as European Pharmacopoeia (Terazosin HCl EP), Terazosin HCl JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Terazosin HCl USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty